Related Experiment Video
Updated: Mar 19, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Maf1, A New PTEN Target Linking RNA and Lipid Metabolism
Deborah L Johnson1, Bangyan L Stiles2
1Baylor College of Medicine, Houston, TX 77030, USA.
Abstract:
PTEN is a critical tumor suppressor whose dysregulation leads to metabolic disease and cancer. How these diseases are linked at a molecular level is poorly understood. Maf1 is a novel PTEN target that connects PTEN's ability to repress intracellular lipid accumulation with its tumor suppressor function. Maf1 represses the expression of rRNAs and tRNAs to restrain biosynthetic capacity and oncogenic transformation. Recent studies demonstrate that Maf1 also controls intracellular lipid accumulation. In animal models, dysregulation of RNA polymerase I- and III-dependent transcription, and subsequent upregulation of rRNAs and tRNAs, leads to altered lipid metabolism and storage. Together these results identify unexpected connections between RNA and lipid metabolism that may help explain the strong epidemiological association between obesity and cancer.
Insights
The tumor suppressor PTEN regulates lipid accumulation and cell growth via Maf1. Maf1 links RNA and lipid metabolism, potentially explaining cancer risks associated with obesity.
Area of Science:
- Molecular Biology
- Oncology
- Metabolism
Background:
- PTEN is a critical tumor suppressor involved in metabolic disease and cancer.
- The molecular link between PTEN dysregulation, metabolic disease, and cancer is not well understood.
- Maf1 is a newly identified PTEN target that plays a role in repressing intracellular lipid accumulation.
Purpose of the Study:
- To investigate the role of Maf1 in connecting PTEN's lipid-regulating functions with its tumor suppressor activity.
- To explore the molecular mechanisms by which Maf1 influences intracellular lipid accumulation and biosynthetic capacity.
- To elucidate the relationship between RNA metabolism and lipid metabolism in the context of cancer development.
Main Methods:
- Investigated Maf1 as a PTEN target.
- Studied Maf1's role in repressing ribosomal RNA (rRNA) and transfer RNA (tRNA) expression.
- Examined the impact of Maf1 on intracellular lipid accumulation.
- Utilized animal models to study the effects of dysregulated RNA polymerase I- and III-dependent transcription on lipid metabolism.
Main Results:
- Maf1 connects PTEN's repression of intracellular lipid accumulation to its tumor suppressor function.
- Maf1 restrains biosynthetic capacity and oncogenic transformation by repressing rRNA and tRNA expression.
- Maf1 was shown to control intracellular lipid accumulation.
- Dysregulation of RNA polymerase I and III transcription, leading to increased rRNA and tRNA levels, altered lipid metabolism and storage in animal models.
Conclusions:
- Maf1 is a key mediator linking PTEN's tumor suppressor functions to the regulation of RNA and lipid metabolism.
- The findings reveal novel connections between RNA metabolism and lipid metabolism.
- These connections may help explain the epidemiological link between obesity and cancer.
- Targeting the RNA-lipid metabolism axis could offer new therapeutic strategies for obesity-related cancers.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
MAPK Signaling Cascades
Regulation of Angiogenesis and Blood Supply
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...

